Cardiac tamponade epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The cardiac tamponade is most often attributed to the rupture of an acute [[myocardial infarction]] or an intrapericardial rupture of a dissecting ascending [[aortic aneurysm]]. In developed countries malignancy is the leading cause of [[cardiac tamponade]] secondary to [[pericardial effusion]]. | The cardiac tamponade is most often attributed to the rupture of an acute [[myocardial infarction]] or an intrapericardial rupture of a dissecting ascending [[aortic aneurysm]]. In developed countries malignancy is the leading cause of [[cardiac tamponade]] secondary to [[pericardial effusion]].The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%). The incidence of cardiac tamponade increases with age; the mean age was around 61.9. Cardiac temponade mortality rate is significantly different due to its underlying cause. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%)<ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology">{{cite web |url=http://www.onlinejacc.org/content/71/11_Supplement/A1155 |title=CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology |format= |work= |accessdate=}}</ref> | *The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%)<ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology">{{cite web |url=http://www.onlinejacc.org/content/71/11_Supplement/A1155 |title=CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology |format= |work= |accessdate=}}</ref><ref name="pmid29493372">{{cite journal |vauthors=Yerdel MA, Şen O, Zor U, Kara S, Acunaş B |title=Cardiac Tamponade as a Life-Threatening Complication of Laparoscopic Antireflux Surgery: The Real Incidence and 3D Anatomy of a Heart Injury by Helical Tacks |journal=J Laparoendosc Adv Surg Tech A |volume=28 |issue=9 |pages=1041–1046 |date=September 2018 |pmid=29493372 |pmc=6157358 |doi=10.1089/lap.2017.0713 |url=}}</ref><ref name="pmid17948086">{{cite journal |vauthors=Ariyarajah V, Spodick DH |title=Cardiac tamponade revisited: a postmortem look at a cautionary case |journal=Tex Heart Inst J |volume=34 |issue=3 |pages=347–51 |date=2007 |pmid=17948086 |pmc=1995065 |doi= |url=}}</ref><ref name="pmid12917306">{{cite journal |vauthors=Spodick DH |title=Acute cardiac tamponade |journal=N. Engl. J. Med. |volume=349 |issue=7 |pages=684–90 |date=August 2003 |pmid=12917306 |doi=10.1056/NEJMra022643 |url=}}</ref> | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
*Cardiac temponade mortality rate is significantly different due to its underlying cause.<ref name="pmid10554845">{{cite journal| author=Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ| title=Pericardoscopy for primary management of pericardial effusion in cancer patients. | journal=Eur J Cardiothorac Surg | year= 1999 | volume= 16 | issue= 3 | pages= 287-91 | pmid=10554845 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10554845 }} </ref><ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology" /> | *Cardiac temponade mortality rate is significantly different due to its underlying cause.<ref name="pmid10554845">{{cite journal| author=Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ| title=Pericardoscopy for primary management of pericardial effusion in cancer patients. | journal=Eur J Cardiothorac Surg | year= 1999 | volume= 16 | issue= 3 | pages= 287-91 | pmid=10554845 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10554845 }} </ref><ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology" /><ref name="pmid27855225">{{cite journal |vauthors=You SC, Shim CY, Hong GR, Kim D, Cho IJ, Lee S, Chang HJ, Ha JW, Chang BC, Chung N |title=Incidence, Predictors, and Clinical Outcomes of Postoperative Cardiac Tamponade in Patients Undergoing Heart Valve Surgery |journal=PLoS ONE |volume=11 |issue=11 |pages=e0165754 |date=2016 |pmid=27855225 |pmc=5113894 |doi=10.1371/journal.pone.0165754 |url=}}</ref> | ||
*Overall, hospitalized mortality rate is around 14.3% and sub groups with higher mortality are : | *Overall, hospitalized mortality rate is around 14.3% and sub groups with higher mortality are : | ||
*#Sepsis (odds ratio:3.17) | *#Sepsis (odds ratio:3.17) | ||
| Line 17: | Line 17: | ||
*#Metastatic cancer:(odds ratio:1.90) | *#Metastatic cancer:(odds ratio:1.90) | ||
*#Acute kidney injury(odds ratio:1.91) | *#Acute kidney injury(odds ratio:1.91) | ||
*#Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality) | *#Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality) | ||
===Age=== | ===Age=== | ||
*The incidence of cardiac tamponade increases with age; the mean age was around 61.9.<ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology" /><ref name="pmid16051963">{{cite journal| author=Gornik HL, Gerhard-Herman M, Beckman JA| title=Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 22 | pages= 5211-6 | pmid=16051963 | doi=10.1200/JCO.2005.00.745 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16051963 }} </ref> | *The incidence of cardiac tamponade increases with age; the mean age was around 61.9.<ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology" /><ref name="pmid16051963">{{cite journal| author=Gornik HL, Gerhard-Herman M, Beckman JA| title=Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 22 | pages= 5211-6 | pmid=16051963 | doi=10.1200/JCO.2005.00.745 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16051963 }} </ref> | ||
| Line 33: | Line 32: | ||
* It needs around 12 days of hospitalization and a mean cost of $160,397. | * It needs around 12 days of hospitalization and a mean cost of $160,397. | ||
===Developed Countries=== | |||
* The leading cause of developing tamponade in developed countries is cancer.<ref name="pmid16051963" /> | |||
==References== | ==References== | ||
Latest revision as of 19:52, 30 March 2020
|
Cardiac tamponade Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac tamponade epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cardiac tamponade epidemiology and demographics |
|
Risk calculators and risk factors for Cardiac tamponade epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
The cardiac tamponade is most often attributed to the rupture of an acute myocardial infarction or an intrapericardial rupture of a dissecting ascending aortic aneurysm. In developed countries malignancy is the leading cause of cardiac tamponade secondary to pericardial effusion.The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%). The incidence of cardiac tamponade increases with age; the mean age was around 61.9. Cardiac temponade mortality rate is significantly different due to its underlying cause.
Epidemiology and Demographics
Incidence
- The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%)[1][2][3][4]
Case-fatality rate/Mortality rate
- Cardiac temponade mortality rate is significantly different due to its underlying cause.[5][1][6]
- Overall, hospitalized mortality rate is around 14.3% and sub groups with higher mortality are :
- Sepsis (odds ratio:3.17)
- Chest trauma (odds ratio:2.15)
- Metastatic cancer:(odds ratio:1.90)
- Acute kidney injury(odds ratio:1.91)
- Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality)
Age
Race
- There is no racial predilection to cardiac tamponade.
Gender
- Cardiac tamponade affects men and women equally.
- There is no study suggesting a meaningful sex difference among diagnosed patients.
Approximate Health Care cost In US
- It needs around 12 days of hospitalization and a mean cost of $160,397.
Developed Countries
- The leading cause of developing tamponade in developed countries is cancer.[7]
References
- ↑ 1.0 1.1 1.2 "CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology".
- ↑ Yerdel MA, Şen O, Zor U, Kara S, Acunaş B (September 2018). "Cardiac Tamponade as a Life-Threatening Complication of Laparoscopic Antireflux Surgery: The Real Incidence and 3D Anatomy of a Heart Injury by Helical Tacks". J Laparoendosc Adv Surg Tech A. 28 (9): 1041–1046. doi:10.1089/lap.2017.0713. PMC 6157358. PMID 29493372.
- ↑ Ariyarajah V, Spodick DH (2007). "Cardiac tamponade revisited: a postmortem look at a cautionary case". Tex Heart Inst J. 34 (3): 347–51. PMC 1995065. PMID 17948086.
- ↑ Spodick DH (August 2003). "Acute cardiac tamponade". N. Engl. J. Med. 349 (7): 684–90. doi:10.1056/NEJMra022643. PMID 12917306.
- ↑ Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ (1999). "Pericardoscopy for primary management of pericardial effusion in cancer patients". Eur J Cardiothorac Surg. 16 (3): 287–91. PMID 10554845.
- ↑ You SC, Shim CY, Hong GR, Kim D, Cho IJ, Lee S, Chang HJ, Ha JW, Chang BC, Chung N (2016). "Incidence, Predictors, and Clinical Outcomes of Postoperative Cardiac Tamponade in Patients Undergoing Heart Valve Surgery". PLoS ONE. 11 (11): e0165754. doi:10.1371/journal.pone.0165754. PMC 5113894. PMID 27855225.
- ↑ 7.0 7.1 Gornik HL, Gerhard-Herman M, Beckman JA (2005). "Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion". J Clin Oncol. 23 (22): 5211–6. doi:10.1200/JCO.2005.00.745. PMID 16051963.